Elena B Pasquale Selected Research

EphA3 Receptor

10/2015	Unliganded EphA3 dimerization promoted by the SAM domain.
2/2012	Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena B Pasquale Research Topics

Disease

54	Neoplasms (Cancer) 03/2022 - 12/2002
10	Pathologic Processes 01/2021 - 10/2008
7	Melanoma (Melanoma, Malignant) 01/2021 - 10/2006
7	Prostatic Neoplasms (Prostate Cancer) 07/2014 - 08/2006
6	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2006
6	Breast Neoplasms (Breast Cancer) 10/2020 - 04/2004
5	Carcinogenesis 01/2013 - 04/2004
3	Squamous Cell Carcinoma of Head and Neck 01/2022 - 12/2016
3	Pathologic Neovascularization 01/2016 - 12/2002
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 12/2017
2	Inflammation (Inflammations) 01/2019 - 01/2016
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 01/2015
2	Glioblastoma (Glioblastoma Multiforme) 12/2012 - 02/2012
1	Leukemia 01/2022
1	Parasitic Diseases (Parasitic Disease) 01/2019
1	Colonic Neoplasms (Colon Cancer) 02/2017
1	Medulloblastoma 04/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2014
1	Atherosclerotic Plaque (Atheroma) 10/2013
1	Plague (Bubonic Plague) 01/2013
1	Kidney Neoplasms (Kidney Cancer) 01/2013
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Liver Neoplasms (Liver Cancer) 02/2012
1	Experimental Melanoma 01/2011
1	Tuberous Sclerosis (Bourneville's Disease) 02/2010
1	Gliosis 01/2009
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2009
1	Wounds and Injuries (Trauma) 10/2008
1	Infections 06/2008

Drug/Important Bio-Agent (IBA)

28	LigandsIBA 01/2021 - 04/2004
23	Phosphotransferases (Kinase)IBA 12/2021 - 04/2004
22	EphrinsIBA 01/2021 - 12/2002
15	EphA1 Receptor (Eph Receptor)IBA 01/2021 - 12/2002
14	Eph Family Receptors (Eph Receptors)IBA 01/2015 - 08/2006
13	EphA2 ReceptorIBA 03/2022 - 12/2002
11	Pharmaceutical PreparationsIBA 01/2022 - 10/2008
11	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 02/2006
11	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2006
8	tyrosine receptor (receptor, tyrosine)IBA 12/2016 - 04/2004
8	Peptides (Polypeptides)IBA 01/2015 - 12/2002
7	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 10/2006
7	EphB4 ReceptorIBA 01/2022 - 08/2006
6	Ephrin-B2 (Ephrin B2)IBA 02/2013 - 04/2004
4	EphA4 ReceptorIBA 01/2019 - 10/2008
3	Biological ProductsIBA 01/2019 - 01/2011
3	Erythropoietin FDA Link 10/2015 - 10/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 07/2014 - 03/2012
3	Ephrin-A1 (Ephrin A1)IBA 10/2013 - 08/2010
2	Messenger RNA (mRNA)IBA 01/2021 - 04/2015
2	AntibodiesIBA 02/2017 - 08/2010
2	EphA3 ReceptorIBA 10/2015 - 02/2012
2	Estrogen Receptor Modulators (Antiestrogen)IBA 04/2014 - 05/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 03/2012
2	Cell Surface ReceptorsIBA 05/2012 - 02/2012
2	IntegrinsIBA 01/2011 - 08/2009
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2022
1	NexusIBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	CarcinogensIBA 01/2022
1	Monomeric GTP-Binding ProteinsIBA 01/2022
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2022
1	Serine (L-Serine)FDA Link 12/2021
1	Threonine (L-Threonine)FDA Link 12/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021
1	CollagenIBA 10/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	atezolizumabIBA 01/2019
1	sortilinIBA 12/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2016
1	EphB1 ReceptorIBA 04/2015
1	Dacarbazine (DIC)FDA LinkGeneric 03/2015
1	Estrogen ReceptorsIBA 04/2014
1	AcidsIBA 04/2013
1	Lithocholic AcidIBA 04/2013
1	Ephrin-A3 (Ephrin A3)IBA 01/2013
1	cholanic acidIBA 06/2012
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2011
1	chondroitin sulfate proteoglycan 4IBA 08/2010
1	Ras Homolog Enriched in Brain ProteinIBA 02/2010
1	Small Interfering RNA (siRNA)IBA 08/2009
1	Sirolimus (Rapamycin)FDA Link 01/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2009
1	Retinaldehyde (Retinal)IBA 10/2008
1	Green Fluorescent ProteinsIBA 06/2008
1	Tva receptorIBA 06/2008
1	Metalloproteases (Metalloproteinases)IBA 08/2006

Therapy/Procedure

12	Therapeutics 01/2022 - 12/2002